EP 4221681 A1 20230809 - ANTI-INFECTIVE DOSAGE FORMS FOR PRODUCING A NASAL RINSE
Title (en)
ANTI-INFECTIVE DOSAGE FORMS FOR PRODUCING A NASAL RINSE
Title (de)
ANTIINFEKTIVE ARZNEIFORMEN ZUR HERSTELLUNG EINER NASENSPÜLUNG
Title (fr)
FORMES GALÉNIQUE ANTI-INFECTIEUSES DESTINÉES À PRODUIRE UN RINÇAGE NASAL
Publication
Application
Priority
- DE 202020004101 U 20200929
- DE 202020004186 U 20201005
- EP 2021076671 W 20210928
Abstract (en)
[origin: WO2022069478A1] Single-dose, water-soluble or water-miscible dosage form for producing a nasal rinse, comprising at least one anti-infective pharmaceutical substance for use in the local treatment of the human nasal cavity. Single-dose, single-use container, comprising the aforementioned single-dose, water-soluble or water-miscible dosage form, wherein the single-use container is preferably selected from the group consisting of sachet, ampule, pouch and spray. Use of the aforementioned single-dose, water-soluble or waster-miscible dosage form for producing a nasal rinse. Use of the aforementioned single-dose, water-soluble or waster-miscible dosage form for introducing a fluid into the human nasal cavity, in particular in a nasal douche. Nasal rinse, comprising at least one anti-infective pharmaceutical substance, wherein the anti-infective pharmaceutical substance is selected from the group consisting of acyclic alcohols, quaternary ammonium compounds, iodine-containing compounds, halogenated compounds, quinoline derivatives, benzoquinone derivatives, phenol derivatives and combinations thereof.
IPC 8 full level
A61K 9/00 (2006.01); A61K 9/08 (2006.01); A61K 9/16 (2006.01); A61K 31/085 (2006.01); A61K 31/155 (2006.01); A61K 31/4425 (2006.01); A61K 31/444 (2006.01); A61P 31/04 (2006.01); A61P 31/12 (2006.01); A61P 31/16 (2006.01)
CPC (source: EP US)
A61K 9/0043 (2013.01 - EP US); A61K 9/08 (2013.01 - EP US); A61K 9/1623 (2013.01 - EP); A61K 9/1635 (2013.01 - EP); A61K 9/1652 (2013.01 - EP); A61K 31/085 (2013.01 - EP); A61K 31/155 (2013.01 - EP US); A61K 31/4425 (2013.01 - EP US); A61K 31/444 (2013.01 - EP US); A61K 31/7004 (2013.01 - US); A61K 47/32 (2013.01 - US); A61K 47/36 (2013.01 - US); A61K 47/38 (2013.01 - US); A61P 31/04 (2017.12 - EP); A61P 31/16 (2017.12 - EP)
Citation (search report)
See references of WO 2022069478A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
Designated validation state (EPC)
KH MA MD TN
DOCDB simple family (publication)
WO 2022069478 A1 20220407; EP 4221681 A1 20230809; US 2023364038 A1 20231116
DOCDB simple family (application)
EP 2021076671 W 20210928; EP 21783512 A 20210928; US 202118029189 A 20210928